Last viewed:
JNJ
Prices are updated after-hours
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
(0.0% 1d)
(-4.8% 1m)
(-8.9% 1y)
(0.0% 2d)
(-1.0% 3d)
(0.2% 7d)
(NaN%
volume)
Earnings Calendar: 2024-01-23
Market Cap: $ 357,925,077,011
http://www.jnj.com
Sec
Filling
|
Patents
| 132200 employees
(US) Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
vaccine
cardiovascular
eye
infectious disease
diabetes
diabetic
hypertension
urea
pulmonary hypertension
women health
immunology
metabolic
women
add to watch list
Paper trade
email alert is off
Press-releases
Pre-Investor Call Presentation available to shareholders
Published: 2024-04-25
(Crawled : 07:00)
- globenewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| Email alert
Add to watchlist
ALSMY
|
News
|
$1.63
-1.78%
430K
|
Manufacturing
| Email alert
Add to watchlist
AOMFF
|
News
|
$16.53
95.45%
25
|
Producer Manufacturing
| Email alert
Add to watchlist
presentation
Why Biopharma Companies Avoid Hiring People Who Need Visas
Published: 2024-04-25
(Crawled : 05:00)
- biospace.com/
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| Email alert
Add to watchlist
companies
avoid
biopharma
Stargardt Disease Market to Grow Rapidly at a CAGR of 32% by 2034 | DelveInsight
Published: 2024-04-24
(Crawled : 22:00)
- prnewswire.com
KOD
|
News
|
$3.37
1.2%
1.19%
340K
|
Health Technology
| Email alert
Add to watchlist
OPT
|
News
|
$3.46
2.98%
2.89%
8.2K
|
Health Technology
| Email alert
Add to watchlist
OTLK
|
News
P
|
$8.2
0.0%
240K
|
Health Technology
| Email alert
Add to watchlist
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| Email alert
Add to watchlist
disease
market
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Published: 2024-04-24
(Crawled : 21:00)
- globenewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| Email alert
Add to watchlist
NBTX
|
$5.71
1.04%
1.4K
|
Manufacturing
| Email alert
Add to watchlist
business
year
update
financial
results
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Published: 2024-04-24
(Crawled : 20:00)
- globenewswire.com
CDTX
|
News
|
$11.94
16.49%
14.15%
170K
|
Health Technology
| Email alert
Add to watchlist
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| Email alert
Add to watchlist
cd388
million
global
commercial
therapeutics
development
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Published: 2024-04-24
(Crawled : 08:00)
- globenewswire.com
ALVO
|
$13.5
0.75%
0.74%
190K
|
n/a
| 1.04%
| O: 1.12%
H: 1.48%
C: -0.07%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -1.02%
| O: -1.02%
H: 0.0%
C: 0.0%
avt05
simponi
biosimilar
for
topline
results
study
Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
Published: 2024-04-24
(Crawled : 07:00)
- prnewswire.com
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -1.02%
| O: -1.02%
H: 0.0%
C: 0.0%
precision
company
million
series
therapeutics
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24
(Crawled : 05:00)
- biospace.com/
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| -0.27%
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB
|
News
|
$1.59
-8.62%
-9.43%
280K
|
| -12.47%
| O: -3.05%
H: 0.0%
C: -9.71%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -1.02%
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT
|
News
|
$0.7051
-5.41%
-5.72%
1.5M
|
Health Technology
| -8.39%
| O: -1.94%
H: 0.0%
C: -6.58%
TXMD
|
News
|
$1.88
-0.27%
15K
|
Health Technology
| 2.13%
| O: 0.53%
H: 2.12%
C: 1.59%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 0.82%
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT
|
News
S
|
$25.19
-0.87%
-0.87%
560K
|
Health Technology
| -2.95%
| O: -0.71%
H: 0.81%
C: -2.25%
NKTR
|
News
|
$1.39
-2.11%
-2.16%
960K
|
Health Technology
| -0.36%
| O: -1.08%
H: 3.65%
C: 0.73%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
| 0.06%
| O: 0.0%
H: 0.28%
C: 0.06%
GLPG
|
News
|
$28.78
-2.28%
-2.33%
140K
|
Health Technology
| -1.41%
| O: 0.48%
H: 0.17%
C: -1.88%
AMRN
|
News
|
$0.8844
0.13%
0.12%
660K
|
Health Technology
| 0.57%
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL
|
News
4
|
$159.18
0.58%
0.58%
22M
|
Technology Services
| 1.34%
| O: 0.29%
H: 1.31%
C: 1.04%
GOOG
|
News
4
|
$161.05
0.71%
0.7%
19M
|
Technology Services
| 1.58%
| O: 0.32%
H: 1.45%
C: 1.26%
OCX
|
News
|
$2.3
-6.31%
-6.74%
41K
|
Health Technology
| 0.0%
| O: 2.03%
H: 0.0%
C: -1.99%
biopharma
Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development
Published: 2024-04-24
(Crawled : 08:00)
- biospace.com/
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -1.02%
| O: -1.02%
H: 0.0%
C: 0.0%
drug
for
therapeutics
development
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
| -0.27%
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB
|
News
|
$1.59
-8.62%
-9.43%
280K
|
| -12.47%
| O: -3.05%
H: 0.0%
C: -9.71%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
| -1.02%
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT
|
News
|
$0.7051
-5.41%
-5.72%
1.5M
|
Health Technology
| -8.39%
| O: -1.94%
H: 0.0%
C: -6.58%
TXMD
|
News
|
$1.88
-0.27%
15K
|
Health Technology
| 2.13%
| O: 0.53%
H: 2.12%
C: 1.59%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
| 0.82%
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT
|
News
S
|
$25.19
-0.87%
-0.87%
560K
|
Health Technology
| -2.95%
| O: -0.71%
H: 0.81%
C: -2.25%
NKTR
|
News
|
$1.39
-2.11%
-2.16%
960K
|
Health Technology
| -0.36%
| O: -1.08%
H: 3.65%
C: 0.73%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
| 0.06%
| O: 0.0%
H: 0.28%
C: 0.06%
GLPG
|
News
|
$28.78
-2.28%
-2.33%
140K
|
Health Technology
| -1.41%
| O: 0.48%
H: 0.17%
C: -1.88%
AMRN
|
News
|
$0.8844
0.13%
0.12%
660K
|
Health Technology
| 0.57%
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL
|
News
4
|
$159.18
0.58%
0.58%
22M
|
Technology Services
| 1.34%
| O: 0.29%
H: 1.31%
C: 1.04%
GOOG
|
News
4
|
$161.05
0.71%
0.7%
19M
|
Technology Services
| 1.58%
| O: 0.32%
H: 1.45%
C: 1.26%
OCX
|
News
|
$2.3
-6.31%
-6.74%
41K
|
Health Technology
| 0.0%
| O: 2.03%
H: 0.0%
C: -1.99%
biopharma
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount